共 50 条
- [22] Efficacy and safety of anlotinib plus anti-PD-1 agents in patients with refractory advanced biliary tract cancers CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (07): : 1647 - 1663
- [23] Biliary tract cancers: moving from the present standards of care towards the use of immune checkpoint inhibitors AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (08): : 8598 - 8610
- [29] Current and emerging therapies for advanced biliary tract cancers LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (11): : 956 - 969